IFNG and neoplasm: Notably, following long-term anti-IFN-γ treatment, the majority of tumours grew progressively (Figure 3D), resulting in significantly reduced survival compared to untreated control or mice receiving short-term anti-IFN-γ treatment (Figure 3E).